Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases.
Journal
Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
13
06
2018
accepted:
10
01
2019
pubmed:
20
2
2019
medline:
20
4
2019
entrez:
20
2
2019
Statut:
ppublish
Résumé
Microbiome-wide association studies on large population cohorts have highlighted associations between the gut microbiome and complex traits, including type 2 diabetes (T2D) and obesity
Identifiants
pubmed: 30778224
doi: 10.1038/s41588-019-0350-x
pii: 10.1038/s41588-019-0350-x
pmc: PMC6441384
mid: NIHMS1014045
doi:
Substances chimiques
Fatty Acids, Volatile
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
600-605Subventions
Organisme : NIDDK NIH HHS
ID : U01 DK105535
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Références
Zhernakova, A. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565–569 (2016).
doi: 10.1126/science.aad3369
Bonder, M. J. et al. The effect of host genetics on the gut microbiome. Nat. Genet. 48, 1407–1412 (2016).
doi: 10.1038/ng.3663
Evans, D. M. & Davey Smith, G. Mendelian randomization: new applications in the coming age of hypothesis-free causality. Annu. Rev. Genomics Hum. Genet. 16, 327–350 (2015).
doi: 10.1146/annurev-genom-090314-050016
Larsen, N. et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5, e9085 (2010).
doi: 10.1371/journal.pone.0009085
Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99–103 (2013).
doi: 10.1038/nature12198
Ley, R. E. et al. Obesity alters gut microbial ecology. Proc. Natl Acad. Sci. USA 102, 11070–11075 (2005).
doi: 10.1073/pnas.0504978102
Kreznar, J. H. et al. Host genotype and gut microbiome modulate insulin secretion and diet-induced metabolic phenotypes. Cell Rep. 18, 1739–1750 (2017).
doi: 10.1016/j.celrep.2017.01.062
Brunkwall, L. & Orho-Melander, M. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities. Diabetologia 60, 943–951 (2017).
doi: 10.1007/s00125-017-4278-3
Kootte, R. S. et al. Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition. Cell Metab. 26, 611–619.e6 (2017).
doi: 10.1016/j.cmet.2017.09.008
Zhang, X. et al. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One 8, e71108 (2013).
doi: 10.1371/journal.pone.0071108
Ríos-Covián, D. et al. Intestinal short chain fatty acids and their link with diet and human health. Front. Microbiol. 7, 185 (2016).
doi: 10.3389/fmicb.2016.00185
Pingitore, A. et al. The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro. Diabetes Obes. Metab. 19, 257–265 (2017).
doi: 10.1111/dom.12811
Chambers, E. S. et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64, 1744–1754 (2015).
doi: 10.1136/gutjnl-2014-307913
Zhao, L. et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 359, 1151–1156 (2018).
doi: 10.1126/science.aao5774
Peng, L., He, Z., Chen, W., Holzman, I. R. & Lin, J. Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr. Res. 61, 37–41 (2007).
doi: 10.1203/01.pdr.0000250014.92242.f3
Schwiertz, A. et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18, 190–195 (2010).
doi: 10.1038/oby.2009.167
Turpin, W. et al. Association of host genome with intestinal microbial composition in a large healthy cohort. Nat. Genet. 48, 1413–1417 (2016).
doi: 10.1038/ng.3693
Goodrich, J. K. et al. Genetic determinants of the gut microbiome in UK Twins. Cell Host Microbe 19, 731–743 (2016).
doi: 10.1016/j.chom.2016.04.017
Rothschild, D. et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 555, 210–215 (2018).
doi: 10.1038/nature25973
Locke, A. E. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197–206 (2015).
doi: 10.1038/nature14177
Shungin, D. et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 518, 187–196 (2015).
doi: 10.1038/nature14132
Manning, A. K. et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat. Genet. 44, 659–669 (2012).
doi: 10.1038/ng.2274
Strawbridge, R. J. et al. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes 60, 2624–2634 (2011).
doi: 10.2337/db11-0415
Soranzo, N. et al. Common variants at 10 genomic loci influence hemoglobin A
doi: 10.2337/db10-0502
Prokopenko, I. et al. A central role for GRB10 in regulation of islet function in man. PLoS Genet. 10, e1004235 (2014).
doi: 10.1371/journal.pgen.1004235
Saxena, R. et al. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat. Genet. 42, 142–148 (2010).
doi: 10.1038/ng.521
Scott, R. A. et al. An expanded genome-wide association study of type 2 diabetes in Europeans. Diabetes 66, 2888–2902 (2017).
doi: 10.2337/db16-1253
Li, Y. et al. A functional genomics approach to understand variation in cytokine production in humans. Cell 167, 1099–1110.e14 (2016).
doi: 10.1016/j.cell.2016.10.017
Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37, 658–665 (2013).
doi: 10.1002/gepi.21758
Verbanck, M., Chen, C. Y., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50, 693–698 (2018).
doi: 10.1038/s41588-018-0099-7
Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304–314 (2016).
doi: 10.1002/gepi.21965
Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512–525 (2015).
doi: 10.1093/ije/dyv080
Bowden, J. et al. Improving the accuracy of two-sample summary data Mendelian randomization: moving beyond the NOME assumption. Preprint at https://www.biorxiv.org/content/early/2018/10/11/159442 (2018).
Rücker, G., Schwarzer, G., Carpenter, J. R., Binder, H. & Schumacher, M. Treatment-effect estimates adjusted for small-study effects via a limit meta-analysis. Biostatistics 12, 122–142 (2011).
doi: 10.1093/biostatistics/kxq046
Bycroft, C. et al. TheUK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018).
doi: 10.1038/s41586-018-0579-z
Duncan, S. H., Hold, G. L., Barcenilla, A., Stewart, C. S. & Flint, H. J. Roseburia intestinalis sp. nov., a novel saccharolytic, butyrate-producing bacterium from human faeces. Int. J. Syst. Evol. Microbiol. 52, 1615–1620 (2002).
pubmed: 12361264
Pryde, S. E., Duncan, S. H., Hold, G. L., Stewart, C. S. & Flint, H. J. The microbiology of butyrate formation in the human colon. FEMS Microbiol. Lett. 217, 133–139 (2002).
doi: 10.1111/j.1574-6968.2002.tb11467.x
Jakobsdottir, G., Bjerregaard, J. H., Skovbjerg, H. & Nyman, M. Fasting serum concentration of short-chain fatty acids in subjects with microscopic colitis and celiac disease: no difference compared with controls, but between genders. Scand. J. Gastroenterol. 48, 696–701 (2013).
doi: 10.3109/00365521.2013.786128
Liu, F. et al. Fructooligosaccharide (FOS) and galactooligosaccharide (GOS) increase Bifidobacterium but reduce butyrate producing bacteria with adverse glycemic metabolism in healthy young population. Sci. Rep. 7, 11789 (2017).
doi: 10.1038/s41598-017-10722-2
Louis, P. & Flint, H. J. Formation of propionate and butyrate by the human colonic microbiota. Environ. Microbiol. 19, 29–41 (2017).
doi: 10.1111/1462-2920.13589
den Besten, G. et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54, 2325–2340 (2013).
doi: 10.1194/jlr.R036012
Kurilshikov, A., Wijmenga, C., Fu, J. & Zhernakova, A. Host genetics and gut microbiome: challenges and perspectives. Trends Immunol. 38, 633–647 (2017).
doi: 10.1016/j.it.2017.06.003
Taylor, A. E. et al. Mendelian randomization in health research: using appropriate genetic variants and avoiding biased estimates. Econ. Hum. Biol. 13, 99–106 (2014).
doi: 10.1016/j.ehb.2013.12.002
Wang, J. et al. Meta-analysis of human genome-microbiome association studies: the MiBioGen consortium initiative. Microbiome 6, 101 (2018).
doi: 10.1186/s40168-018-0479-3
Tigchelaar, E. F. et al. Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics. BMJ Open 5, e006772 (2015).
doi: 10.1136/bmjopen-2014-006772
Li, N. et al. Pleiotropic effects of lipid genes on plasma glucose, HbA1c, and HOMA-IR levels. Diabetes 63, 3149–3158 (2014).
doi: 10.2337/db13-1800
García-Villalba, R. et al. Alternative method for gas chromatography-mass spectrometry analysis of short-chain fatty acids in faecal samples. J. Sep. Sci. 35, 1906–1913 (2012).
doi: 10.1002/jssc.201101121
Schirmer, M. et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell 167, 1125–1136.e8 (2016).
doi: 10.1016/j.cell.2016.10.020
McCarthy, S. et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet. 48, 1279–1283 (2016).
doi: 10.1038/ng.3643
Franzosa, E. A. et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat. Methods 15, 962–968 (2018).
doi: 10.1038/s41592-018-0176-y
Vatanen, T. et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 165, 842–853 (2016).
doi: 10.1016/j.cell.2016.04.007
Kang, H. M. et al. Variance component model to account for sample structure in genome-wide association studies. Nat. Genet. 42, 348–354 (2010).
doi: 10.1038/ng.548
Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
doi: 10.1038/ng.3211
Loh, P. R. et al. Efficient Bayesian mixed-model analysis increases association power in large cohorts. Nat. Genet. 47, 284–290 (2015).
doi: 10.1038/ng.3190
Eastwood, S. V. et al. Algorithms for the capture and adjudication of prevalent and incident diabetes in UK Biobank. PLoS One 11, e0162388 (2016).
doi: 10.1371/journal.pone.0162388